<DOC>
	<DOC>NCT00825396</DOC>
	<brief_summary>The purpose of this study is to determine the safety and tolerability of topical C-KAD Ophthalmic Solution in reducing intraocular pressure in patients with ocular hypertension.</brief_summary>
	<brief_title>An Open-Label Study of an Ophthalmic Solution to Reduce Intraocular Pressure in Patients With Ocular Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Both eyes having intraocular pressure in the range of 2230 mmHg at baseline Both eyes having best corrected visual acuity better than 20/50 Advanced glaucoma Closed or barely open anterior chamber or history of angle closure</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>June 2009</verification_date>
</DOC>